troxacitabine has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adema, AD; Alexander, LE; Cho, JH; Chu, CK; Daft, JR; Hoebe, EK; Peters, GJ; Radi, M | 1 |
Bussom, S; Cheng, YC; Lam, W | 1 |
Boivin, AJ; Gourdeau, H; Momparler, RL | 1 |
3 other study(ies) available for troxacitabine and Lung Neoplasms
Article | Year |
---|---|
In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 2007 |
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cytosine; Deoxycytidine; Dioxolanes; Dose-Response Relationship, Drug; Gemcitabine; Hemodynamics; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Proteins; Phosphoglycerate Kinase; Response Elements; Transcription, Genetic; Xenograft Model Antitumor Assays | 2009 |
Action of troxacitabine on cells transduced with human cytidine deaminase cDNA.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cytarabine; Cytidine Deaminase; Cytosine; Dioxolanes; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Transduction, Genetic; Tumor Cells, Cultured | 2004 |